K. S. Liem Et Al. , "Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.49, no.4, pp.448-456, 2019
Liem, K. S. Et Al. 2019. Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.49, no.4 , 448-456.
Liem, K. S., van Campenhout, M. J. H., Xie, Q., Brouwer, W. P., Chi, H., Qi, X., ... Chen, L.(2019). Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B. ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.49, no.4, 448-456.
Liem, Kin Et Al. "Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B," ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.49, no.4, 448-456, 2019
Liem, Kin S. Et Al. "Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.49, no.4, pp.448-456, 2019
Liem, K. S. Et Al. (2019) . "Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B." ALIMENTARY PHARMACOLOGY & THERAPEUTICS , vol.49, no.4, pp.448-456.
@article{article, author={Kin Seng Liem Et Al. }, title={Low hepatitis B surface antigen and HBV DNA levels predict response to the addition of pegylated interferon to entecavir in hepatitis B e antigen positive chronic hepatitis B}, journal={ALIMENTARY PHARMACOLOGY & THERAPEUTICS}, year=2019, pages={448-456} }